Komori
Earnings9267Genky DrugStores Co.,Ltd.Retail

Summary of Financial Results for the First Quarter of the Fiscal Year Ending June 2027 [Japanese GAAP] (Consolidated)

In the first quarter, revenue increased 6.2% year on year, driven by factors including the expansion of store openings, while operating profit and all lower profit measures fell below the year-earlier levels. The full-year revenue and profit forecasts, as well as the annual dividend forecast, remain unchanged.

Worth reading
36Immaterial
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Mixed performance
Direction inferred from the company’s description.
Scale
6.2
Year-on-year change in net sales (%)
Wording
Conditional
How definitive the wording is.

Results for this period

First quarter21 June 2026–20 September 2026ConsolidatedJapanese GAAP
Net Sales59,503¥ millionYear on year +6.2%Progress 24.4%
Operating profit2,762¥ millionYear on year -5.3%Progress 23.0%
Ordinary income2,740¥ millionYear on year -7.4%Progress 22.6%
Net income attributable to owners of the parent1,878¥ millionYear on year -7.8%Progress 22.9%

The width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit. The dotted outline is the full-year forecast and the band inside it is the result for this period. The progress rate is the result divided by the forecast.

Net income per share¥61.57
Financial position at period-end
Total assets152,844¥ million
of which net assets 63,061 ¥ millionEquity ratio 41.1%vs. prior year-end -0.9pt

塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。The thin vertical line indicates the level at the end of the previous fiscal year.

Outlook and shareholder returns
Full-year earnings forecast
Net Sales¥244,000 million (YoY +10.6%)
Operating profit¥12,000 million (YoY +9.2%)
Ordinary income¥12,100 million (YoY +8.4%)
Net income¥8,200 million (YoY +4.1%)
Annual Dividend Forecast¥13.00 → ¥13.00(0.0%)
Factors Behind Changes in Business Performance

The company advanced the development of dominant areas to increase its regional market share through concentrated store openings, further low-cost operations, and discounts on essential goods.

Disclosure regarding the going concern assumption

None

Change in accounting policy
基準改正に伴う変更 Noneそれ以外の変更 None見積りの変更 None修正再表示 None
Changes in the scope of consolidation0 additions and 0 exclusions (no company names)
Breakdown of extraordinary income (loss)Extraordinary income Gain on reversal of stock acquisition rights ¥0 million / Extraordinary loss Loss on disposal and sale of property, plant and equipment ¥1 million
Depreciation and amortization¥1,872 million
Availability of Supplementary Financial Results MaterialsYes
Availability of Financial Results BriefingWhether applicable None / Subject person Not disclosed
Issued Shares at Period-End31,044,568 Shares
Treasury Shares at Period-End532,069 Shares
Results for this period
ItemDetails
Fiscal Period ClassificationFirst quarter
Accounting standardsJapanese GAAP
Consolidated / non-consolidatedConsolidated
Period Covered21 June 2026–20 September 2026
Net Sales¥59,503 million (YoY +6.2%)
Operating profit¥2,762 million (YoY -5.3%)
Ordinary income¥2,740 million (YoY -7.4%)
Profit attributable to owners of the parent¥1,878 million (YoY -7.8%)
Net income per share¥61.57
Equity ratioEnd of the current fiscal period 41.1 / End of previous period 42
Total assets¥152,844 million
Net assets¥63,061 million
Full-year earnings forecastNet Sales ¥244,000 million (YoY +10.6%) / Operating profit ¥12,000 million (YoY +9.2%) / Ordinary income ¥12,100 million (YoY +8.4%) / Net income ¥8,200 million (YoY +4.1%)
Annual Dividend Forecast¥13.00 → ¥13.00(0.0%)
Depreciation and amortization¥1,872 million
Breakdown of extraordinary income (loss)Extraordinary income Gain on reversal of stock acquisition rights ¥0 million / Extraordinary loss Loss on disposal and sale of property, plant and equipment ¥1 million
Disclosure regarding the going concern assumptionNone
Change in accounting policyChanges due to revisions to standards None / Other changes None / Change in accounting estimate None / Restatement None
Changes in the scope of consolidation0 additions and 0 exclusions (no company names)
Availability of Supplementary Financial Results MaterialsYes
Availability of Financial Results BriefingWhether applicable None / Subject person Not disclosed
Issued Shares at Period-End31,044,568 Shares
Treasury Shares at Period-End532,069 Shares
Factors Behind Changes in Business PerformanceThe company advanced the development of dominant areas to increase its regional market share through concentrated store openings, further low-cost operations, and discounts on essential goods.
Items this document does not state (14)
Operating MarginCash flows from operating activitiesCash flows from investing activitiesCash flows from financing activitiesCash and cash equivalents at end of periodRevision to Earnings ForecastPayout ratioShareholder Return PolicySegment revenueSegment profitRegional salesOrders received and order backlogImpairment lossMaterial subsequent events

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

The company said it advanced the development of dominant areas through concentrated store openings, pursued further low-cost operations, and expanded discounts on essential goods. It also said that consumer sentiment became more cautious and that consumers increasingly focused on saving as prices rose.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Summary of Financial Results for the First Quarter of the Fiscal Year Ending June 2027 [Japanese GAAP] (Consolidated) | Genky DrugStores Co.,Ltd. (9267) timely disclosure | Komori